他汀类药物主要预防低脂水平 ,但Ｃ反应蛋白(ＣＲＰ)水平升高的病人对冠脉事件可能有效。他汀类药物已显示降低首次冠脉事件的危险 ,但用于一线预防尚未普及 ,因为需要药物预防 1次临床事件的病人数量相当大 ,这种方法的费用又很大。事实上 ,发生所有冠脉事件的半数病人 ,并非 Statins are primarily for the prevention of low-fat levels, but patients with elevated levels of C-reactive protein (CRP) may be effective on coronary events. Statins have been shown to reduce the risk of first-time coronary events, but first-line prevention has not yet become widely available because of the sheer size of the need for medications to prevent a single clinical event, which is costly. In fact, half of all patients with coronary events do not